Skip to main content
Institute for Social Vision Design

Health & Medicine

11 items

Insights & Analysis

Japan's Second-Hand Smoke Law Seven Years In — The Revised Health Promotion Act and Regional Variation in Indoor-Smoking Rules

Six years after the April 2020 full enforcement of Japan's revised Health Promotion Act covering second-hand smoke, restaurant categories, schools and government buildings, and local ordinances reveal substantial unevenness in how indoor-smoking restrictions are operated and which residents are protected.

Insights & Analysis

Japan's 2024 Problem One Year In — Working Hour Caps on Trucking, Construction, and Doctors and the Gap Between Rule and Reality

More than a year after the April 2024 enforcement of Japan's working-style reform on the three delayed sectors (commercial driving, construction, medical doctors), this column maps the gap between rule design and on-the-ground operations across trucking volumes, construction timelines, and physician work.

Insights & Analysis

Chemical Management and SDS Compliance: Legal Reform and the Burden Structure on Japanese SMEs

Japan's Industrial Safety and Health Act was amended in two phases (April 2023 and April 2024). The number of chemical substances subject to labeling, SDS notification, and risk assessment has expanded in stages from about 674 before the amendment, to about 896 in April 2024, to about 1,600 in April 2025, with a further staged expansion to roughly 2,900 substances from April 2026. The duty to appoint a chemical substance manager applies regardless of industry, scale, or quantity, and localizing SDS documents from overseas manufacturers has become the responsibility of importers. Starting from FIRST-HAND Local's reporting on a medical-research reagent SME in Tokyo, this article reads the burden structure of Japan's shift to autonomous chemical management from the perspective of small and medium-sized enterprises.

Insights & Analysis

Time Asymmetry in Pediatric Care: How Japan's 71.9% Dual-Income Reality Collides with Medical Access

71.9% of Japan's married households are now dual-income: 13 million households strong. Maternal employment continuation after the first child has climbed to 69.5%. Yet pediatric care hours remain anchored to weekday daytime. Tottori at 187.3 vs. Chiba at 101.5: a 1.85x gap. Sick-child daycare is absent in 39.6% of municipalities. The 2024 physician work-style reform adds new tension. This article reads "time", the invisible third variable of medical access, through primary data.

Insights & Analysis

Bound by the Phone: The Structure That Distorts Nursing Labor Quality and Time Allocation

A nurse's primary work is direct patient care. Yet international time-motion studies have repeatedly shown that direct care occupies only 20-38% of total nursing work time. The remainder is consumed by documentation and coordination, especially the relentless phone calls to chase down family signatures within seven days. Starting from a Hyogo Prefecture case reported by FIRST-HAND Local in April 2026, this column layers Japan's MHLW research findings (daily nursing records are the leading cause of overtime), the operational gap of the Discharge Support Add-on A246 7-day requirement, and the Dutch Buurtzorg model record only what is meaningful principle to re-read nursing labor quality from the institutional design side.

Insights & Analysis

Japan's Late-Elderly Medical Premium Cap Raised from ¥800K to ¥850K (FY2026): Pinpoint Increase on the Top 1.2% and Its Spillover to Middle and Lower Incomes

On December 12, 2025, the Health Insurance Subcommittee of Japan's Social Security Council approved a plan to raise the annual premium cap for the late-elderly medical care system from ¥800K to ¥850K starting FY2026, with a new ¥21K Child-Care Support Levy portion added separately from April 2026, bringing the combined cap to ¥871K. The increase targets enrollees with annual pension-plus-salary income of ¥11.5M or more — approximately 1.2% of all enrollees. Headlines read "premiums rise for the 75-plus generation," but the institutional logic is different: a pinpoint cap increase on the top 1.2% slows premium growth for the remaining 98.8%. A model case at ¥4M annual income shows FY2026 premiums of about ¥297K (+4.2% year-over-year). This article unpacks the MHLW design, the meaning of "1.2% of enrollees," the new ¥21K Child-Care Support Levy, and the often-conflated distinction between intra-generational ability-based redistribution and inter-generational benefit structure.

Insights & Analysis

The Polypharmacy Problem in Japan's Elderly — Why 40% Take 5 or More Medications

About 40% of Japanese adults aged 75+ are prescribed 5 or more medications, and roughly 25% take 7 or more. Once the threshold of 6 drugs is crossed, adverse drug events increase significantly. Prescribing cascades, fragmented care, and psychological barriers to deprescribing perpetuate this structural problem.

Insights & Analysis

695,000 Licensed Nurses Not at Work — The Structure of Nurse Attrition and the 7-to-1 Staffing Trap

Japan faces a paradox: a job-to-applicant ratio of 2.47x alongside 695,000 licensed nurses who are not practicing. This article dissects the 7-to-1 staffing standard that concentrates nurses in large hospitals, the diagnostic fee structure that suppresses wages, and a reality where 52.5% of new graduate resignations cite mental illness.

Insights & Analysis

Is Noise 'Invisible Violence'? — Health Risks Warned by the WHO and Japan's Regulatory Vacuum

A disease burden of 1.6 million DALYs annually attributable to noise represents a level that cannot be overlooked. Cardiovascular disease, sleep disorders, cognitive impairment — the WHO ranks noise as the 'second-largest environmental risk factor after air pollution.' This article examines, through data, both the international comparison of Japan's regulatory standards and the actual extent of health harm caused by noise.

Insights & Analysis

The Economic Rationality of Preventive Medicine: Social Design in the Era of 48 Trillion Yen Healthcare Costs

Structural analysis of the cost-effectiveness of preventive medicine investment. Comparing healthcare expenditure breakdown and preventive ROI.

Insights & Analysis

The Structure of ¥48 Trillion in Medical Expenses — A Turning Point for Sustainability Toward 2030

Japan's medical expenses hit ¥48.09 trillion in FY2023—a record high. As spending grows relentlessly, the healthcare system faces sustainability challenges.